Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience.
Jeon YW, Yoon S, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG.
Jeon YW, et al. Among authors: park ss, park s.
Cancer Med. 2019 Nov;8(16):6860-6870. doi: 10.1002/cam4.2565. Epub 2019 Sep 27.
Cancer Med. 2019.
PMID: 31560165
Free PMC article.